BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 8973572)

  • 1. Human microglia convert l-tryptophan into the neurotoxin quinolinic acid.
    Heyes MP; Achim CL; Wiley CA; Major EO; Saito K; Markey SP
    Biochem J; 1996 Dec; 320 ( Pt 2)(Pt 2):595-7. PubMed ID: 8973572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 4-Chloro-3-hydroxyanthranilate, 6-chlorotryptophan and norharmane attenuate quinolinic acid formation by interferon-gamma-stimulated monocytes (THP-1 cells).
    Saito K; Chen CY; Masana M; Crowley JS; Markey SP; Heyes MP
    Biochem J; 1993 Apr; 291 ( Pt 1)(Pt 1):11-4. PubMed ID: 8471029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A mechanism of quinolinic acid formation by brain in inflammatory neurological disease. Attenuation of synthesis from L-tryptophan by 6-chlorotryptophan and 4-chloro-3-hydroxyanthranilate.
    Heyes MP; Saito K; Major EO; Milstien S; Markey SP; Vickers JH
    Brain; 1993 Dec; 116 ( Pt 6)():1425-50. PubMed ID: 8293279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human macrophages convert L-tryptophan into the neurotoxin quinolinic acid.
    Heyes MP; Saito K; Markey SP
    Biochem J; 1992 May; 283 ( Pt 3)(Pt 3):633-5. PubMed ID: 1534219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different kynurenine pathway enzymes limit quinolinic acid formation by various human cell types.
    Heyes MP; Chen CY; Major EO; Saito K
    Biochem J; 1997 Sep; 326 ( Pt 2)(Pt 2):351-6. PubMed ID: 9291104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of indoleamine 2,3-dioxygenase and production of quinolinic acid by human microglia, astrocytes, and neurons.
    Guillemin GJ; Smythe G; Takikawa O; Brew BJ
    Glia; 2005 Jan; 49(1):15-23. PubMed ID: 15390107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poliovirus induces indoleamine-2,3-dioxygenase and quinolinic acid synthesis in macaque brain.
    Heyes MP; Saito K; Jacobowitz D; Markey SP; Takikawa O; Vickers JH
    FASEB J; 1992 Aug; 6(11):2977-89. PubMed ID: 1322853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kynurenine pathway enzymes in brain: responses to ischemic brain injury versus systemic immune activation.
    Saito K; Nowak TS; Suyama K; Quearry BJ; Saito M; Crowley JS; Markey SP; Heyes MP
    J Neurochem; 1993 Dec; 61(6):2061-70. PubMed ID: 8245962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of immune activation on quinolinic acid and neuroactive kynurenines in the mouse.
    Saito K; Markey SP; Heyes MP
    Neuroscience; 1992 Nov; 51(1):25-39. PubMed ID: 1465184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of the kynurenine pathway enzymes in human microglia and macrophages.
    Guillemin GJ; Smith DG; Smythe GA; Armati PJ; Brew BJ
    Adv Exp Med Biol; 2003; 527():105-12. PubMed ID: 15206722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism of L-tryptophan to kynurenate and quinolinate in the central nervous system: effects of 6-chlorotryptophan and 4-chloro-3-hydroxyanthranilate.
    Naritsin DB; Saito K; Markey SP; Chen CY; Heyes MP
    J Neurochem; 1995 Nov; 65(5):2217-26. PubMed ID: 7595510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activated human microglia produce the excitotoxin quinolinic acid.
    Espey MG; Chernyshev ON; Reinhard JF; Namboodiri MA; Colton CA
    Neuroreport; 1997 Jan; 8(2):431-4. PubMed ID: 9080423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Species heterogeneity between gerbils and rats: quinolinate production by microglia and astrocytes and accumulations in response to ischemic brain injury and systemic immune activation.
    Heyes MP; Saito K; Chen CY; Proescholdt MG; Nowak TS; Li J; Beagles KE; Proescholdt MA; Zito MA; Kawai K; Markey SP
    J Neurochem; 1997 Oct; 69(4):1519-29. PubMed ID: 9326281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of the kynurenine metabolic pathway by interferon-gamma in murine cloned macrophages and microglial cells.
    Alberati-Giani D; Ricciardi-Castagnoli P; Köhler C; Cesura AM
    J Neurochem; 1996 Mar; 66(3):996-1004. PubMed ID: 8769859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterisation of kynurenine pathway metabolism in human astrocytes and implications in neuropathogenesis.
    Guillemin GJ; Smith DG; Kerr SJ; Smythe GA; Kapoor V; Armati PJ; Brew BJ
    Redox Rep; 2000; 5(2-3):108-11. PubMed ID: 10939285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A beta 1-42 induces production of quinolinic acid by human macrophages and microglia.
    Guillemin GJ; Smythe GA; Veas LA; Takikawa O; Brew BJ
    Neuroreport; 2003 Dec; 14(18):2311-5. PubMed ID: 14663182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of delayed increases in kynurenine pathway metabolism in damaged brain regions following transient cerebral ischemia.
    Saito K; Nowak TS; Markey SP; Heyes MP
    J Neurochem; 1993 Jan; 60(1):180-92. PubMed ID: 8417138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuronal localization of indoleamine 2,3-dioxygenase in mice.
    Roy EJ; Takikawa O; Kranz DM; Brown AR; Thomas DL
    Neurosci Lett; 2005 Oct; 387(2):95-9. PubMed ID: 16076525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kynurenine pathway metabolism in human astrocytes: a paradox for neuronal protection.
    Guillemin GJ; Kerr SJ; Smythe GA; Smith DG; Kapoor V; Armati PJ; Croitoru J; Brew BJ
    J Neurochem; 2001 Aug; 78(4):842-53. PubMed ID: 11520905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The kynurenine pathway activities in a sub-Saharan HIV/AIDS population.
    Bipath P; Levay PF; Viljoen M
    BMC Infect Dis; 2015 Aug; 15():346. PubMed ID: 26285873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.